9 min listen
Exploring Pharmacogenomic Testing in MDD
Exploring Pharmacogenomic Testing in MDD
ratings:
Length:
9 minutes
Released:
Nov 13, 2023
Format:
Podcast episode
Description
Can pharmacogenomic testing improve the selection and dosing of antidepressants in patients with MDD? In this episode, we explore the findings of the PRIME Care trial and discuss the clinical significance of these tests. Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 49 Effect of Pharmacogenomic Testing for Drug–Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial
Released:
Nov 13, 2023
Format:
Podcast episode
Titles in the series (100)
FGAs and SGAs for Managing Explosive Behavior: In this episode, we discuss the SGAs with the most evidence for explosive behavior, their side effects, and monitoring recommendations. We also address the reasons for considering other SGAs and clarify which FGA has the most evidence for aggression.... by Psychopharmacology and Psychiatry Updates